logo

For the Inventor, By the Inventor

Wembley, United Kingdom

Gordon H Phillipps

USPTO Granted Patents = 28

Average Co-Inventor Count = 2.7

ph-index = 7

Forward Citations = 372(Granted Patents)


Location History:

  • Greenford, EN (1976)
  • Wembley, EN (1976 - 1978)
  • Wembley, GB (1980 - 1990)

Company Filing History:

goldMedal17 out of 1,168 
 
Glaxo Group Limited
 patents
silverMedal11 out of 97 
 
Glaxo Laboratories Limited
 patents

Years Active: 1976-1990

Loading Chart...
28 patents (USPTO):Explore Patents
1. 4959371 - Isoquinoline derivatives with anti-tumor activity (1990-09-25),
2. 4933457 - Preparation of (1990-06-12),
3. 4900737 - Isoquinoline derivatives (1990-02-13),
4. 4851399 - Isoquinoline derivatives and their use as anti-cancer agents (1989-07-25),
5. 4835158 - Isoquinoline derivatives (1989-05-30),
6. 4831039 - Isoquinoline compound (1989-05-16),
7. 4650800 - Substituted pyrimidin-2-ones, the salts thereof, pharmaceutical (1987-03-17),
8. 4650610 - Androstane carbothioic acids (1987-03-17),
9. 4636509 - Substituted pyrimidin-2-ones, the salts thereof, processes for their (1987-01-13),
10. 4578221 - Androstane carbothioic acids (1986-03-25),
11. 4515786 - 11.alpha.-Amino-androstanes (1985-05-07),
12. 4497805 - 11.alpha.-amino-androstanes (1985-02-05),
13. 4451405 - 11.alpha.-Amino-3.beta.-hydroxy-androstanes (1984-05-29),
14. 4353898 - 11.alpha.-Amino-androstanes (1982-10-12),
15. 4352798 - 11 .alpha.-Amino-androstanes (1982-10-05),

Title: Innovations of Gordon H. Phillipps: A Journey through Patents and Collaborations

Introduction: Gordon H. Phillipps, located in Wembley, GB, is a distinguished inventor known for his significant contributions in the field of pharmaceuticals. With a total of 28 patents to his name, his work primarily focuses on the development of compounds with potential anti-tumor activity.

Latest Patents: His latest patent, titled "Isoquinoline derivatives with anti-tumor activity", describes a range of compounds that demonstrate promising properties as anticancer agents. The patent includes a detailed process for synthesizing these compounds, highlighting the innovative methodologies involved in creating effective treatments. The compounds of the general formula provided in the patent contribute to the synthesis of anticancer agents, showcasing Gordon’s dedication to advancing medical science through his inventions.

Career Highlights: Throughout his career, Gordon has made remarkable advancements in pharmaceutical research. He has worked with notable organizations such as Glaxo Group Limited and Glaxo Laboratories Limited, where he explored and developed various innovative compounds. His expertise in chemical synthesis and drug development has established him as a leading figure in the field.

Collaborations: Collaborating with esteemed colleagues like Christopher Earle Newall and George B. Ewan has further enriched Gordon's contributions to science. These collaborations have fostered an environment of shared knowledge and innovation, propelling the development of effective therapeutic agents.

Conclusion: Gordon H. Phillipps stands out as a prominent inventor in the realm of pharmaceuticals, illustrated by his extensive list of patents and innovative compounds. His ongoing work continues to contribute significantly to the development of new treatments, paving the way for advancements in cancer therapy. His achievements highlight the importance of collaboration and innovation in the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…